Research at Fox Chase »Technology Transfer »Symposium

Fox Chase Cancer Center
Research and Technology Symposium

The Office of Corporate Alliances (formerly the Office of Business Development) at the Fox Chase Cancer Center held its inaugural Research and Technology Symposium on Tuesday, May 20, 2008, at The Academy of Natural Sciences, 1900 Benjamin Franklin Parkway, Philadelphia.

During the Symposium, researchers provided an overview of Fox Chase's broad array of nationally competitive basic, translational, and clinical research, including its special programs in cancer prevention, detection and treatment.

Review slide presentations from the inaugural
Research and Technology Symposium

Agenda

(The following links requires Adobe® Acrobat Reader to view.)
8:00-8:45	Breakfast and Registration
8:45-8:50	Kurt Schwinghammer, PhD, Assistant Vice President, Office of Corporate Alliances: Introduction to the Day
8:50-9:00	J. Robert Beck, MD, Chief Academic Officer; Office of the President: Welcoming Remarks
9:00-9:20	Kerry Campbell, PhD: A Genetically-modified NK Cell Line Expressing the Fc Receptor, CD16, for Use in ADCC Assays	pdf
9:20-9:40	Erica Golemis, PhD: Informatics-guided Screening Approaches to Improving Cancer Therapy	pdf
9:40-10:00	Denise Connolly, PhD: Using Mouse Models to Study Ovarian Tumor Biology	pdf
10:00-10:20	Glenn Rall, PhD: Double Trouble: How Concomitant Immune Challenges can Result in Neurological Disease	pdf
10:20-10:40	Coffee Break
10:40-11:00	Annette Tobia, PhD, JD; Founder & CEO: Dynamis Therapeutics: A Fox Chase Start-up Focused on New Drugs to Treat Chronic Inflammatory Disease	pdf
11:00-11:20	Roland Dunbrack, PhD: Methods for Protein Structure Prediction	pdf
11:20-11:40	Gregory Adams, PhD: Engineered Antibody-based Molecules for the Treatment of Ovarian Cancer	pdf
11:40-12:00	Jonathan Chernoff, MD, PhD: P21-activated Kinases: New Targets in Cancer Therapeutics	pdf
12:00-12:20	Jeffrey Peterson, PhD: Chemical Genetic Approaches to Inhibitor Discovery	pdf
12:20-1:40	Lunch and Poster Presentation — For a List of Featured Posters and Technologies Click HERE
1:40-2:00	Elizabeth Henske, MD: Tuberous Sclerosis Research: Unlocking the Pathogenesis of Cancer, Autism, and More	pdf
2:00-2:20	David Wiest, PhD: Exploration of the Prognostic Value of Rpl22 Mutations in T-acute Lymphoblastic Leukemia	pdf
2:20-2:40	Margie Clapper, PhD: Strategies for the Early Detection and Prevention of Cancer in Mouse Models	pdf
2:40-3:00	Kenneth Zaret, PhD: From Science to Stem Cell Therapeutics: Opportunities for Licensing and Collaboration	pdf
3:00-3:15	Coffee Break
3:20-3:40	Alfonso Bellacosa, MD, PhD: Markers for Early Diagnosis and Prevention of Cancer	pdf
3:40-4:00	Luis J. Sigal, DVM, PhD: A Novel Concept for Antiviral Vaccines and Therapies	pdf
4:00-4:20	Nancy Lewis, MD: Fox Chase Phase I Clinical Trial Program: An Overview	pdf

For more information about the technologies featured at the Symposium,, please contact the Office of Corporate Alliances.